Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanotechnology eye drops for dry eye
RBR-8mj25hxCompleted
- Sponsor
- Cetos Therapeutics
- Start
- Jun 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in dry eye syndrome (DED), sponsored by Cetos Therapeutics. Started Jun 2022; status: completed.
02
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on RBR-8mj25hx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8mj25hx.